Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 2/2011

01-02-2011

Risk factors for haemorrhage during local intra-arterial thrombolysis for lower limb ischaemia

Authors: M. Kuoppala, J. Åkeson, P. Svensson, B. Lindblad, S. Franzen, S. Acosta

Published in: Journal of Thrombosis and Thrombolysis | Issue 2/2011

Login to get access

Abstract

Assessment of clinical risk factors for haemorrhagic complications in patients undergoing intra-arterial thrombolysis for lower limb ischaemia. Retrospective reviews of consecutive patients subjected to intra-arterial thrombolysis due to lower limb ischemia at the Vascular Center, Malmö University Hospital, during a 5-year period from 2001 to 2005. Two hundred and twenty intra-arterial thrombolytic procedures were carried out in 195 patients (46% women), median age 73 years. Haemorrhagic complications were recorded in 72 procedures (33%), of which 13 were discontinued. Haemorrhage at the introducer and distant sites occurred in 53 and 32 procedures, respectively. Thrombolysis for occluded synthetic grafts was associated with higher risk of haemorrhage (P = 0.043). The platelet count was lower (P = 0.017) and the dose of alteplas higher (P = 0.041) in bleeders than in non-bleeders. Age was not associated with haemorrhage (P = 0.30). Two patients died during thrombolysis, one of them due to intracerebral haemorrhage. The grade of thrombolysis was an independent predictor of both in-hospital amputation (P < 0.001; OR 3.5 [95% CI 2.1–5.8]) and mortality (P = 0.021; OR 3.0 [95% CI 1.2–7.9]). The in-hospital amputation-free survival rate was 85% (188/220). Haemorrhage associated with thrombolysis is common, but does seldom require discontinuation of treatment. Insertion of introducers for local thrombolysis through synthetic grafts, lower platelet count and higher alteplas dose were found to be risk factors for haemorrhage. An algorithm for clinical management of haemorrhage has been proposed.
Literature
1.
go back to reference Kessel DO, Berridge DC, Robertsson I (2002) Surgery versus thrombolysis for acute limb ischaemia: initial management. Cochrane Database Syst Rev 3:CD002784 Kessel DO, Berridge DC, Robertsson I (2002) Surgery versus thrombolysis for acute limb ischaemia: initial management. Cochrane Database Syst Rev 3:CD002784
2.
go back to reference Kessel DO, Berridge DC, Robertsson I (2004) Infusion techniques for peripheral arterial thrombolysis. Cochrane Database Syst Rev 1:CD000985 Kessel DO, Berridge DC, Robertsson I (2004) Infusion techniques for peripheral arterial thrombolysis. Cochrane Database Syst Rev 1:CD000985
3.
go back to reference Kuoppala M, Franzén S, Lindblad B, Acosta S (2008) Long-term prognostic factors after thrombolysis for lower limb ischemia. J Vasc Surg 47:1243–1250CrossRefPubMed Kuoppala M, Franzén S, Lindblad B, Acosta S (2008) Long-term prognostic factors after thrombolysis for lower limb ischemia. J Vasc Surg 47:1243–1250CrossRefPubMed
4.
go back to reference Management of peripheral arterial disease (PAD) (2000) TransAtlantic InterSociety Consensus (TASC). Section C: acute limb ischemia. Eur J Vasc Endovasc Surg 19(suppl A):S115–S143 Management of peripheral arterial disease (PAD) (2000) TransAtlantic InterSociety Consensus (TASC). Section C: acute limb ischemia. Eur J Vasc Endovasc Surg 19(suppl A):S115–S143
5.
go back to reference Earnshaw JJ, Whitman B, Foy C (2004) National Audit of Thrombolysis for Acute Leg Ischemia (NATALI): clinical factors associated with early outcome. J Vasc Surg 39:1018–1025CrossRefPubMed Earnshaw JJ, Whitman B, Foy C (2004) National Audit of Thrombolysis for Acute Leg Ischemia (NATALI): clinical factors associated with early outcome. J Vasc Surg 39:1018–1025CrossRefPubMed
6.
go back to reference Ouriel K, Veith FJ, Sasahar AA (1998) A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators. N Engl J Med 16:1105–1111CrossRef Ouriel K, Veith FJ, Sasahar AA (1998) A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators. N Engl J Med 16:1105–1111CrossRef
7.
go back to reference The STILE Investigators (1994) Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial. Ann Surg 220:251–266CrossRef The STILE Investigators (1994) Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial. Ann Surg 220:251–266CrossRef
8.
go back to reference Swischuk JL, Fox PF, Young PF, Young K, Hussain S, Smouse B, Castaneda F (2001) Transcatheter intraarterial infusion of rt-PA for acute lower limb ischemia: results and complications. J Vasc Interv Radiol 12:423–430CrossRefPubMed Swischuk JL, Fox PF, Young PF, Young K, Hussain S, Smouse B, Castaneda F (2001) Transcatheter intraarterial infusion of rt-PA for acute lower limb ischemia: results and complications. J Vasc Interv Radiol 12:423–430CrossRefPubMed
9.
go back to reference Schulman S, Beyth RJ, Kearon C, Levine MN (2008) Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 133:257S–298SCrossRefPubMed Schulman S, Beyth RJ, Kearon C, Levine MN (2008) Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 133:257S–298SCrossRefPubMed
10.
go back to reference Sobel M, Verhaeghe R (2008) Antithrombotic therapy for peripheral artery occlusive disease: American College of Chest Physicians Evidence-Based Clinical practice Guidelines (8th edition). Chest 133:815S–843SCrossRefPubMed Sobel M, Verhaeghe R (2008) Antithrombotic therapy for peripheral artery occlusive disease: American College of Chest Physicians Evidence-Based Clinical practice Guidelines (8th edition). Chest 133:815S–843SCrossRefPubMed
11.
go back to reference Gore JM, Granger CB, Simoons ML et al (1995) Stroke after thrombolysis: mortality and functional outcomes in the GUSTO-I trial; Global Use of Strategies to Open Occluded Coronary Arteries. Circulation 92:2811–2818PubMed Gore JM, Granger CB, Simoons ML et al (1995) Stroke after thrombolysis: mortality and functional outcomes in the GUSTO-I trial; Global Use of Strategies to Open Occluded Coronary Arteries. Circulation 92:2811–2818PubMed
12.
go back to reference Gurwitz JH, Gore JM, Goldberg RJ et al (1998) Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction: participants in the National Registry of Myocardial Infarction 2. Ann Intern Med 129:597–604PubMed Gurwitz JH, Gore JM, Goldberg RJ et al (1998) Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction: participants in the National Registry of Myocardial Infarction 2. Ann Intern Med 129:597–604PubMed
13.
go back to reference Faggioli GL, Peer R, Pedrini L et al (1994) Failure of thrombolytic therapy to improve long-term vascular patency. J Vasc Surg 19:289–297PubMed Faggioli GL, Peer R, Pedrini L et al (1994) Failure of thrombolytic therapy to improve long-term vascular patency. J Vasc Surg 19:289–297PubMed
14.
go back to reference Si TG, Guo Z, Hao XS (2008) Can catheter-directed thrombolysis be applied to acute lower extremity artery embolism after recent cerebral embolism from atrial fibrillation ? Clin Radiol 63:1136–1141CrossRefPubMed Si TG, Guo Z, Hao XS (2008) Can catheter-directed thrombolysis be applied to acute lower extremity artery embolism after recent cerebral embolism from atrial fibrillation ? Clin Radiol 63:1136–1141CrossRefPubMed
15.
go back to reference Sica D (2002) The implications of renal impairment among patients undergoing percutaneous coronary intervention. J Invasive Cardiol 14:30B–37BPubMed Sica D (2002) The implications of renal impairment among patients undergoing percutaneous coronary intervention. J Invasive Cardiol 14:30B–37BPubMed
16.
go back to reference Kuukasjärvi P, Salenius JP, Riekkinen H (1995) Prognostic value of preoperative C-reactive protein concentration and white cell count in acute extremity ischaemia. Eur J Surg 161:335–339PubMed Kuukasjärvi P, Salenius JP, Riekkinen H (1995) Prognostic value of preoperative C-reactive protein concentration and white cell count in acute extremity ischaemia. Eur J Surg 161:335–339PubMed
17.
go back to reference Mahler F, Schneider E, Hess H (2001) Recombinant tissue plasminogen activator versus urokinase for local thrombolysis of femoro-popliteal occlusions: a prospective, randomized multicenter trial. J Endovasc Ther 8:638–647CrossRefPubMed Mahler F, Schneider E, Hess H (2001) Recombinant tissue plasminogen activator versus urokinase for local thrombolysis of femoro-popliteal occlusions: a prospective, randomized multicenter trial. J Endovasc Ther 8:638–647CrossRefPubMed
18.
go back to reference Stainsby D, MacLennan S, Thomas D, Isaac J, Hamilton PJ (2006) British Committee for Standards in Haematology: guidelines on the management of massive blood loss. Br J Haem 135:634–641CrossRef Stainsby D, MacLennan S, Thomas D, Isaac J, Hamilton PJ (2006) British Committee for Standards in Haematology: guidelines on the management of massive blood loss. Br J Haem 135:634–641CrossRef
19.
go back to reference Leissinger C, Blatt P, Hoots W, Ewenstein B (2008) Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature. Am J Hematol 83:137–143CrossRefPubMed Leissinger C, Blatt P, Hoots W, Ewenstein B (2008) Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature. Am J Hematol 83:137–143CrossRefPubMed
20.
go back to reference Lorenz R, Kienast J, Otto U, Kiehl M, Schreiter D, Haertel S, Barthels M (2007) Succesful emergency reversal of phenprocoumon anticoagulation with prothrombin complex concentrate: a prospective clinical study. Blood Coagul Fibrinolysis 18:565–570CrossRefPubMed Lorenz R, Kienast J, Otto U, Kiehl M, Schreiter D, Haertel S, Barthels M (2007) Succesful emergency reversal of phenprocoumon anticoagulation with prothrombin complex concentrate: a prospective clinical study. Blood Coagul Fibrinolysis 18:565–570CrossRefPubMed
21.
go back to reference Key N, Negrier C (2007) Transfusion medicine 3. Coagulation factor concentrates: past, present and future. Lancet 370:439–448CrossRefPubMed Key N, Negrier C (2007) Transfusion medicine 3. Coagulation factor concentrates: past, present and future. Lancet 370:439–448CrossRefPubMed
Metadata
Title
Risk factors for haemorrhage during local intra-arterial thrombolysis for lower limb ischaemia
Authors
M. Kuoppala
J. Åkeson
P. Svensson
B. Lindblad
S. Franzen
S. Acosta
Publication date
01-02-2011
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 2/2011
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-010-0520-2

Other articles of this Issue 2/2011

Journal of Thrombosis and Thrombolysis 2/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.